IPO
IPO
Best Performers
Forthcoming Issues
Closed Issues
New Listings
Current Issues
IPO Performance
IPO News
IPO Analysis
Basis of Allotment
Draft Prospectus
  HOME  >  IPO  >   IPO SNAPSHOT
IPO Snapshot    
Hamps Bio Ltd.
Issue Open Date 13-Dec-24  
Issue Closing Date 17-Dec-24  
Application Money 100  
Allotment Money  
Price Band 51 -  
Minimium Application No. 2000  
Issue Size (Shares) 1220000  
Market Lot 1.00  
Objective
1. Purchase of plant & machinery for FMCG division.2. Enhancing the visibility and awareness of our brand.3. General corporate purposes.
Category No. of Shares No. of Shares Subscription Ratio
  Offered / Reserved Bid For  
Non-Institutional Investors     439098000   NA  
Qualified Institutional Buyers     7934000   NA  
Retail Individual Investors     777042000   NA  
Business Description
We are engaged in the ethical marketing and distribution of pharmaceutical formulation products (“Pharma”) across wide range of dosage including tablets, syrups, capsules, injectables, oil, gel and powder used as medicine and nutrition supplements as well as t
more...
Promoter's Holding
Total Share Capital   3136000  
Offered to Public   1220000  
Promoter's Holding (Pre-Issue)   100  
Promoter's Holding (Post-Issue)   71.99  
Address
2900/112
G I D C
Near Atul Limited
Ankleshwar
Bharuch ,
Gujarat ,
393002
Phone: 8000006663
Email: info@hampsbio.com
Website: www.hampsbio.com
Registrar
Bigshare Services Pvt Ltd
Office No S6-2
6th Floor
Pinnacle Business Park
Next to Ahura Centre
Mahakali Caves Road
Andheri (E)
Mumbai
Listed at
BSE
Lead Manager
Marwadi Chandarana Intermediaries Brokers Pvt Ltd.
Promoters
Herrik Shah
Herrik Shah HUF
Mitali Shah
Pallavi Shah
Shrenik Shah
Shrenik Shah HUF
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.